Britain announced on Wednesday an agreement with GlaxoSmithKline and Sanofi Pasteur.
Coronavirus has created a furor worldwide. Worldwide, work is underway on a corona vaccine. Clinical trials of the third phase of several vaccines are going on. Meanwhile, before the vaccine is ready, many countries are making deals to buy it.
In the same sequence, Britain announced on Wednesday an agreement with GlaxoSmithKline and Sanofi Pasteur. Under this deal was done for doses of around six crore vaccines.
British Business Minister Alok Sharma said, 'Our scientists and researchers are working to develop a safe and effective vaccine at the fastest pace ever. Progress in this direction is truly remarkable, but the fact remains that there is no guarantee of success in it.
In the meantime, it is important that we have tied up with companies like GSK and Sanofi, who are developing the vaccine, so that the scope of effective vaccine can be increased and we can save the lives of people. '
If GSK and Sanofi's vaccine proves effective in human studies, Britain will be able to vaccinate priority groups, including frontline health workers and social care workers.
This will be done by the summer of 2021. The clinical study of vaccines on humans will begin in September, the third phase of which will be studied in December 2020.
With the latest announcement, the government has said that it has reached four different types of vaccines and 25 crore doses ahead of time. Earlier this month, the British government announced that it had arranged nine crore doses of the Covid-19 vaccine, in partnership with the Biotech / Pfizer alliance and Walneva.